The NK cell–cancer cycle: advances and new challenges in NK cell–based immunotherapies
Natural killer (NK) cells belong to the innate immune system and contribute to protecting the
host through killing of infected, foreign, stressed or transformed cells. Additionally, via …
host through killing of infected, foreign, stressed or transformed cells. Additionally, via …
Multispecific drugs herald a new era of biopharmaceutical innovation
RJ Deshaies - Nature, 2020 - nature.com
The modern biopharmaceutical industry traces its roots to the dawn of the twentieth century,
coincident with marketing of aspirin—a signature event in the history of modern drug …
coincident with marketing of aspirin—a signature event in the history of modern drug …
Cancer cell-derived exosomal circUHRF1 induces natural killer cell exhaustion and may cause resistance to anti-PD1 therapy in hepatocellular carcinoma
PF Zhang, C Gao, XY Huang, JC Lu, XJ Guo, GM Shi… - Molecular cancer, 2020 - Springer
Objective Natural killer (NK) cells play a critical role in the innate antitumor immune
response. Recently, NK cell dysfunction has been verified in various malignant tumors …
response. Recently, NK cell dysfunction has been verified in various malignant tumors …
[HTML][HTML] NK cell metabolism and tumor microenvironment
I Terrén, A Orrantia, J Vitallé… - Frontiers in …, 2019 - frontiersin.org
Natural Killer (NK) cells are characterized by their potential to kill tumor cells by different
means without previous sensitization and have, therefore, become a valuable tool in cancer …
means without previous sensitization and have, therefore, become a valuable tool in cancer …
Chimeric antigen receptor-engineered natural killer cells for cancer immunotherapy
A Yilmaz, H Cui, MA Caligiuri, J Yu - Journal of hematology & oncology, 2020 - Springer
Natural killer (NK) cells are a critical component of the innate immune system. Chimeric
antigen receptors (CARs) re-direct NK cells toward tumor cells carrying corresponding …
antigen receptors (CARs) re-direct NK cells toward tumor cells carrying corresponding …
Oncolytic viruses for cancer therapy: barriers and recent advances
M Zheng, J Huang, A Tong, H Yang - Molecular Therapy-Oncolytics, 2019 - cell.com
Oncolytic viruses (OVs) are powerful new therapeutic agents in cancer therapy. With the first
OV (talimogene laherparepvec [T-vec]) obtaining US Food and Drug Administration …
OV (talimogene laherparepvec [T-vec]) obtaining US Food and Drug Administration …
[HTML][HTML] CAR-NK cells: from natural basis to design for kill
Chimeric antigen receptors (CARs) are fusion proteins with an extracellular antigen
recognition domain and numerous intracellular signaling domains that have been …
recognition domain and numerous intracellular signaling domains that have been …
DNAM-1 and the TIGIT/PVRIG/TACTILE axis: novel immune checkpoints for natural killer cell-based cancer immunotherapy
B Sanchez-Correa, I Valhondo, F Hassouneh… - Cancers, 2019 - mdpi.com
Natural killer (NK) cells are lymphocytes of the innate immune response characterized by
their role in the destruction of tumor cells. Activation of NK cells depend on a fine balance …
their role in the destruction of tumor cells. Activation of NK cells depend on a fine balance …
Natural killer cells as allogeneic effectors in adoptive cancer immunotherapy
KB Lupo, S Matosevic - Cancers, 2019 - mdpi.com
Natural killer (NK) cells are attractive within adoptive transfer settings in cancer
immunotherapy due to their potential for allogeneic use; their alloreactivity is enhanced …
immunotherapy due to their potential for allogeneic use; their alloreactivity is enhanced …
Hallmarks of resistance to immune-checkpoint inhibitors
M Karasarides, AP Cogdill, PB Robbins… - Cancer immunology …, 2022 - AACR
Abstract Immune-checkpoint inhibitors (ICI), although revolutionary in improving long-term
survival outcomes, are mostly effective in patients with immune-responsive tumors. Most …
survival outcomes, are mostly effective in patients with immune-responsive tumors. Most …